Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002184
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Phase II Stratified Randomized Double-Blind Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil ADF at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors PI and Nucleoside Reverse Transcriptase Inhibitors RTI for the Treatment of HIV-Infected Patient
Sponsor:
Gilead Sciences
Organization:
NIH AIDS Clinical Trials Information Service
Organization Data
Organization:
NIH AIDS Clinical Trials Information Service
Class:
INDUSTRY
Study ID:
232E
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gilead Sciences
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None